Overview ZIAGEN® Post-marketing Surveillance Status: Completed Trial end date: 2015-02-05 Target enrollment: Participant gender: Summary An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and efficacy of ZIAGEN® administered in Korean patients according to the prescribing information. Details Lead Sponsor: ViiV HealthcareCollaborator: GlaxoSmithKlineTreatments: Abacavir